HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma soluble fibrin monomer complex as a marker of coronary thrombotic events in patients with acute myocardial infarction.

Abstract
Soluble fibrin monomer appears in the bloodstream during the extremely early stage of blood coagulation and generally forms a complex with fibrinogen, termed soluble fibrin monomer complex (FMC). Determination of FMC can provide information regarding the state of thrombotic diseases; thus it is important to investigate whether FMC serves as an early indicator of myocardial infarction (MI). We investigated hemostatic and fibrinolytic parameters including FMC to determine their capabilities for indicating thrombotic conditions in the coronary artery. Blood samples from 47 patients with acute MI were obtained within 48 hours (acute phase) and during 120 - 600 hours (recovery phase), respectively, after MI onset. Plasma FMC was significantly elevated in the acute phase, compared with that during the recovery phase and in healthy controls (p = 0.001), suggesting that its elevation indicates thrombotic events in the coronary artery of MI patients. D-dimer, a marker of thrombus formation accompanied with fibrinolysis, was increased in both phases in the patients. In addition, FMC and D-dimer were significantly increased within 24 hours after onset as compared to 24 - 48 hours (p = 0.003 and p = 0.011). Furthermore, cardiac troponin T, a marker of myocardial damage, was significantly higher after 24 hours than within the first 24 hours (p = 0.001). Receiver operating characteristic (ROC) analysis of FMC for early MI diagnosis indicates that FMC, rather than D-dimer, is a better marker within 24 hours of onset. Measuring plasma FMC may be useful for early diagnosis of MI recurrence and deciding primary treatment.
AuthorsMasahiro Ieko, Sumiyoshi Naito, Mika Yoshida, Kaoru Kanazawa, Kazuhiro Mizukami, Harumi Sato, Tomoo Yui, Toru Nakabayashi, Takayuhi Hirabayashi, Yutaka Oguma
JournalThe Tohoku journal of experimental medicine (Tohoku J Exp Med) Vol. 219 Issue 1 Pg. 25-31 (Sep 2009) ISSN: 1349-3329 [Electronic] Japan
PMID19713681 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • Troponin T
  • alpha-Macroglobulins
  • antithrombin III-protease complex
  • fibrin fragment D
  • fibrinmonomer
  • plasmin-alpha(2)-macroglobulin complex
  • Antithrombin III
  • Creatine Kinase
  • Creatine Kinase, MB Form
  • Peptide Hydrolases
  • Fibrinolysin
Topics
  • Aged
  • Aged, 80 and over
  • Antithrombin III
  • Biomarkers (blood)
  • Coronary Thrombosis (blood, diagnosis, etiology)
  • Creatine Kinase (blood)
  • Creatine Kinase, MB Form (blood)
  • Female
  • Fibrin Fibrinogen Degradation Products (analysis, metabolism)
  • Fibrinolysin (metabolism)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, complications)
  • Peptide Hydrolases (blood)
  • ROC Curve
  • Troponin T (blood)
  • alpha-Macroglobulins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: